Defence

Defence Therapeutics is a biotechnology company dedicated to designing the next generation of vaccines and ADC products using its proprietary platform. Defence's core AccumTM technology enables the precise delivery of vaccine antigens or ADCs in their intact form to target cells, enhancing the efficacy and potency against catastrophic diseases such as cancer and infectious diseases. In addition, the company is developing multiple R&D pipelines based on the AccumTM platform for the treatment of diseases like lymphoma and melanoma. It is believed that with continuous efforts and innovation, this technology will provide a brand-new option for ADC cancer treatment.